|
NAF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81503999999721E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.53870000000023E-05 |
| Normal-vs-Stage2 |
7.395600E-03 |
| Normal-vs-Stage3 |
1.92488999999352E-05 |
| Normal-vs-Stage4 |
2.191000E-04 |
| Stage1-vs-Stage2 |
9.725600E-01 |
| Stage1-vs-Stage3 |
3.399000E-01 |
| Stage1-vs-Stage4 |
5.305800E-01 |
| Stage2-vs-Stage3 |
6.081600E-01 |
| Stage2-vs-Stage4 |
7.241000E-01 |
| Stage3-vs-Stage4 |
8.527800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.044830E-04 |
| Normal-vs-AfricanAmerican |
7.504000E-02 |
| Normal-vs-Asian |
4.954900E-04 |
| Caucasian-vs-AfricanAmerican |
4.770200E-01 |
| Caucasian-vs-Asian |
6.129600E-01 |
| AfricanAmerican-vs-Asian |
3.087200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.23929999782536E-08 |
| Normal-vs-Female |
2.380900E-04 |
| Male-vs-Female |
1.978300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.023400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.0122999999983E-05 |
| Normal-vs-Age(61-80Yrs) |
5.61799999999613E-05 |
| Normal-vs-Age(81-100Yrs) |
6.476200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.676600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.836010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.402800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.000600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.486200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.604600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.585900E-02 |
| Classical-VS-Follicular |
9.03510000149765E-08 |
| Classical-VS-Other |
9.635600E-02 |
| Classical-VS-Normal |
4.441200E-03 |
| Tall-VS-Follicular |
2.281900E-02 |
| Tall-VS-Other |
2.641200E-01 |
| Tall-VS-Normal |
1.382260E-04 |
| Follicular-VS-Other |
9.586400E-01 |
| Follicular-VS-Normal |
5.14070008783563E-10 |
| Other-VS-Normal |
9.661400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56819000000086E-05 |
| Normal-vs-N1 |
3.359200E-04 |
| N0-vs-N1 |
8.490800E-01 |
|
|
